Electronic Supplementary Material
Download File(s)
cbm-17-1-227_ESM.pdf (489 KB)
References
1
Kamran SC, Riaz N, Lee N. Nasopharyngeal carcinoma. Surg Oncol Clin N Am. 2015; 24: 547–61.
2
Blanchard P, Lee A, Marguet S, Leclercq J, Ng W, Ma J, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015; 16: 645–55.
3
Zhang EP, Lian PG, Cai KL, Chen YF, Cai MD, Zheng XF, et al. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys. 1989; 16: 301–5.
4
Leung TW, Tung SY, Sze WK, Wong FC, Yuen KK, Lui CM, et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck. 2005; 27: 555–65.
5
Zhang L, Zhu YX, Wang Y, Huang CP, Wu Y, Ji QH. Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience. Ann Surg Oncol. 2011; 18: 233–8.
6
Lo WC, Wang CP, Ko JY, Lou PJ, Yang TL, Wang CW, et al. Salvage treatment for isolated regional failure of nasopharyngeal carcinoma after primary radiotherapy. Ann Surg Oncol. 2012; 19: 1001–8.
7
Na’ara S, Amit M, Billan S, Cohen JT, Gil Z. Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis. Ann Surg Oncol. 2014; 21: 3056–62.
8
Divi V, Harris J, Harari PM, Cooper JS, McHugh J, Bell D, et al. Establishing quality indicators for neck dissection: correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer. 2016; 122: 3464–71.
9
Ebrahimi A, Clark JR, Zhang WJ, Elliott MS, Gao K, Miltoss CG, et al. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck 2011; 33: 1245–51.
10
Lee S, Kim HJ, Cha IH, Nam W. Prognostic value of lymph node count from selective neck dissection in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018; 47: 953–8.
11
Divi V, Chen MM, Nussenbaum B, Rhoads KF, Sirjani DB, Holsinger FC, et al. Lymph node count from neck dissection predicts mortality in head and neck cancer. J Clin Oncol. 2016; 34: 3892–7.
12
You R, Zou X, Wang SL, Jiang R, Tang LQ, Zhang WD, et al. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system. Eur J Cancer. 2015; 51: 1771–9.
13
Chan RC, Chan JY. Impact of nodal ratio on survival in recurrent nasopharyngeal carcinoma. Head Neck. 2015; 37: 12–7.
14
Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, et al. Metastatic lymph node burden and survival in oral cavity cancer. J Clin Oncol. 2017; 35: 3601–9.
15
Vasan K, Low TH, Gupta R, Ashford B, Asher R, Gao K, et al. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma. Head Neck. 2018; 40: 993–9.
16
Safi AF, Kauke M, Grandoch A, Nickenig HJ, Zoller J, Kreppel M. The importance of lymph node ratio for patients with mandibular infiltration of oral squamous cell carcinoma. J Craniomaxillofac Surg. 2018; 46: 1007–12.
17
Park YM, Wang SG, Lee JC, Shin DH, Kim IJ, Son SM, et al. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: a prognostic factor of locoregional recurrence. Head Neck. 2016; 38(Suppl 1): E1172–76.
18
Passoni NM, Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, et al. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection. Urol Oncol. 2014; 32: 29.e21–8.
19
Nguyen DP, Kent M, Vilaseca A, Corradi RB, Fossati N, Sjoberg DD, et al. Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy. Prostate Cancer Prostatic Dis. 2017; 20: 105–9.
20
Kim MK, Park HS, Kim JY, Kim S, Nam S, Park S, et al. The clinical implication of the number of lymph nodes harvested during sentinel lymph node biopsy and its effects on survival outcome in patients with node-negative breast cancer. Am J Surg. 2017; 214: 726–32.
21
Feng Z, Xu QS, Wang C, Li JZ, Mao MH, Li H, et al. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancer. Sci Rep. 2017; 7: 6708.
22
Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, et al. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol. 2012; 48: 329–36.
23
Shrime MG, Bachar G, Lea J, Volling C, Ma C, Gullane PJ, et al. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009; 31: 1482–8.
24
Marres CC, de Ridder M, Hegger I, van Velthuysen ML, Hauptmann M, Navran A, et al. The influence of nodal yield in neck dissections on lymph node ratio in head and neck cancer. Oral Oncol. 2014; 50: 59–64.
25
Ricarte-Filho J, Ganly I, Rivera M, Katabi N, Fu W, Shaha A, et al. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid. 2012; 22: 575–84.
26
Chan YW, Lee VH, Chow VL, To VS, Wei WI. Extracapsular lymph node spread in recurrent nasopharyngeal carcinoma. Laryngoscope. 2011; 121: 2576–80.
27
Kim KY, Le QT, Yom SS, Pinsky BA, Bratman SV, Ng RH, et al. Current state of PCR-based Epstein-Barr virus DNA testing for nasopharyngeal cancer. J Natl Cancer Inst. 2017; 109: djx007.
